Angiogenesis effects of 4-methoxy benzyl alcohol on cerebral ischemia-reperfusion injury via regulation of VEGF-Ang/Tie2 balance

Can J Physiol Pharmacol. 2021 Dec;99(12):1253-1263. doi: 10.1139/cjpp-2021-0118. Epub 2021 Jul 20.

Abstract

Angiogenesis facilitates the formation of microvascular networks and promotes neurological deficit recovery after cerebral ischemia-reperfusion injury (CIRI). This study investigated the angiogenesis effects of 4-methoxy benzyl alcohol (4-MA) on CIRI. The angiogenesis effects of 4-MA and the potential underlying mechanisms were assessed based on a middle cerebral artery occlusion/reperfusion (MCAO/R) rat model and a hind limb ischemic (HLI) mouse model. Immunofluorescence was conducted to detect microvessel density, and Western blotting and polymerase chain reaction were performed to determine the expression of angiogenesis-promoting factors. In addition, we investigated whether the angiogenesis effects of 4-MA caused damage to the blood-brain barrier (BBB). After treatment with 4-MA (20 mg/kg) for 7 days, the neurological deficits recovered and microvessel density in the cerebral cortex increased in the MCAO/R rats. Additionally, 4-MA also regulated the expression of angiogenesis factors, with an increase in vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor 2 (VEGFR-2) expression and a decrease in angiopoietin 1 (Ang-1), Ang-2, and Tie-2 expression in both MCAO/R rats and HLI mice. Moreover, 4-MA increased the expression of angiogenesis-promoting factors without exacerbating BBB cascade damage in MCAO/R rats. Our results indicated that 4-MA may contribute to the formation of microvascular networks, thus promoting neurological deficit recovery after CIRI.

Keywords: 4-methoxybenzyl alcohol; alcool 4 méthoxybenzylique; angiogenesis; angiogenèse; blood–brain barrier permeability; maturation vasculaire; perméabilité de la barrière hématoencéphalique; vascular maturation.

MeSH terms

  • Angiogenesis Inducing Agents*
  • Angiopoietin-1 / genetics
  • Angiopoietin-1 / metabolism
  • Angiopoietin-2 / genetics
  • Angiopoietin-2 / metabolism
  • Animals
  • Benzyl Alcohol / administration & dosage*
  • Benzyl Alcohol / pharmacology*
  • Blood-Brain Barrier / metabolism
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / genetics
  • Brain Ischemia / metabolism
  • Disease Models, Animal
  • Gene Expression / drug effects
  • Gene Expression / genetics
  • Male
  • Mice
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, TIE-2 / genetics
  • Receptor, TIE-2 / metabolism
  • Reperfusion Injury / drug therapy*
  • Reperfusion Injury / genetics
  • Reperfusion Injury / metabolism
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism*
  • Vascular Endothelial Growth Factor Receptor-2 / genetics
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism*

Substances

  • Angiogenesis Inducing Agents
  • Angiopoietin-1
  • Angiopoietin-2
  • Vascular Endothelial Growth Factor A
  • Kdr protein, rat
  • Receptor, TIE-2
  • Tek protein, mouse
  • Vascular Endothelial Growth Factor Receptor-2
  • Benzyl Alcohol